Xlife Sciences Ltd. header image

Xlife Sciences Ltd.

XLS

Equity

ISIN CH0461929603 / Valor 46192960

SIX Swiss Exchange (2026-06-25)
CHF 20.20-3.35%

Xlife Sciences Ltd.
UMushroom community rating:

star star star star star
3.50 2 votes No rating yet
NegativeNeutralPositive

About company

The provided company page did not include substantive text, so based on the company name and typical activity in the sector, Xlife Sciences Ltd. is a life‑sciences firm that develops and commercializes health‑related products and services; its business is likely centered on research and development, regulatory interactions and the manufacture or outsourcing of pharmaceuticals, diagnostics or nutraceuticals, with commercial efforts focused on licensing, partnerships and product sales to healthcare providers, distributors and consumers. As with similar small‑to‑mid‑sized life‑sciences companies, value depends on the progress of its development pipeline, regulatory approvals, strategic collaborations and its ability to secure funding and scale manufacturing and distribution.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

1.00%1Y
-47.4%3Y
-60.0%5Y

Performance

62.2%1Y
63.4%3Y
58.8%5Y

Volatility

Market cap

143 M

Market cap (USD)

Daily traded volume (Shares)

9,682

Daily traded volume (Shares)

1 day high/low

25.9 / 24.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.50

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Timo R
Switzerland, 16 Apr 2025
star star star star star
.
Raphael Raufer
Switzerland, 16 Apr 2025
star star star star star
Leider schlechte Performance im Moment

EQUITIES OF THE SAME SECTOR

Amylyx Pharmaceuticals Inc
Amylyx Pharmaceuticals Inc Amylyx Pharmaceuticals Inc Valor: 115580129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.59%USD 17.44
Corcept Therapeutics Inc
Corcept Therapeutics Inc Corcept Therapeutics Inc Valor: 1812837
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.91%USD 84.75
HealthEquity Inc
HealthEquity Inc HealthEquity Inc Valor: 24679014
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.85%USD 83.43
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%USD 24.73
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.23%USD 28.43
Spire Healthcare Group PLC
Spire Healthcare Group PLC Spire Healthcare Group PLC Valor: 24881418
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.80%GBP 2.18
Elekta AB
Elekta AB Elekta AB Valor: 613625
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.75%SEK 47.66
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.78%SEK 309.80
Protagonist Therapeutics Inc
Protagonist Therapeutics Inc Protagonist Therapeutics Inc Valor: 33278818
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.39%USD 122.63
Biogaia AB
Biogaia AB Biogaia AB Valor: 118922125
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.08%SEK 119.70